RK-4
Clinical trials for RK-4 explained in plain language.
Never miss a new study
Get alerted when new RK-4 trials appear
Sign up with your email to follow new studies for RK-4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Skull injection shows promise for severe stroke patients
Disease control Not yet recruitingThis early-phase study tests a new drug called RK-4 for people with a severe type of stroke (large hemispheric infarction) who cannot have standard treatment. The drug is injected directly into the skull bone marrow once daily for three days. The main goals are to check if the dr…
Matched conditions: RK-4
Phase: PHASE1, PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New bone marrow injection aims to help severe stroke patients
Disease control Not yet recruitingThis study tests a new drug called RK-4 for people who have had a severe stroke and cannot receive standard treatment to reopen blocked blood vessels. The drug is injected into the skull bone marrow daily for three days. Researchers want to see if it helps patients recover better…
Matched conditions: RK-4
Phase: PHASE2 • Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 12, 2026 13:41 UTC